Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03255824 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 144
- Enrollment target
NCT03255824 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 144 participants.
The verdict
NCT03255824, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 144 participants
- Enrollment target
Study Summary
Hypothesis: A combination of midazolam with dexmedetomidine for sedation during third molar surgery will provide 1) superior patient satisfaction, 2) superior operator satisfaction and 3) no significant hemodynamic or respiratory changes when compared to a sedation combination of midazolam, fentanyl and propofol for sedation during third molar surgery.
Interventions
- DRUG Dexmedetomidine and Midazolam
- DRUG Propofol, Midazolam, and Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2019-12-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03255824
The ClinicalTrials.gov registry entry for NCT03255824 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine and Midazolam is the first listed.
NCT03255824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03255824 about?
NCT03255824 is a clinical study titled "A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation". Hypothesis: A combination of midazolam with dexmedetomidine for sedation during third molar surgery will provide 1) superior patient satisfaction, 2) superior operator satisfaction and 3) no significant hemodynamic or respiratory changes when compared to a sedation combination of midazolam, fentanyl...
What is the current status of trial NCT03255824?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 144 participants. The study started on 2018-03-20. Estimated completion is 2019-12-27.
What interventions are being tested in trial NCT03255824?
The interventions under investigation include: Dexmedetomidine and Midazolam (DRUG), Propofol, Midazolam, and Fentanyl (DRUG).
Who is sponsoring clinical trial NCT03255824?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.